Altogether, members of the specialty collected nearly 5,800 of these payments in 2024, from sources such as pharmaceutical companies and imaging device manufacturers.
Medmo and Covera Health, both based in New York, officially announced their merger on April 21, with the latter’s lead investor, Insight Partners, funding the deal.
Speaking at a Politico health care policy forum, CMS Administrator Mehmet Oz, MD, said he supports Medicaid, adding that “when you love something, you protect it.”
The insurance giant has been piloting a program to speed up reimbursement to hospitals in 10 states, reducing delays by roughly 50%. Now, the company said it will work to lift prior authorization barriers on patient care delivery. The intent is to roll out these changes nationwide by the end of 2026, UnitedHealthcare confirmed.
By and large, U.S. hospitals and health systems do not have an AI adoption problem. But many—if not most—have an execution problem: They struggle to turn a set of installed AI tools into a measurable operational value.
Family physicians and other primary care providers don’t mind being held to account for care quality by healthcare administrators. The rub is that multiple other stakeholders often demand similar levels of answerability, pulling the doctors in different directions at once.
Developed by a board-certified diagnostic and interventional radiologist, the platform was trained using subspecialty data that general AI applications typically lack.
Heart Rhythm 2026 in Chicago will include a total of 18 late-breaking clinical trials—and that is just the beginning. The four-day event kicks off April 23.
The FDA asked, and Eli Lilly and Company delivered. The company now hopes to secure an additional approval for orforglipron/Foundayo that covers the treatment of type 2 diabetes.
Of all lawsuits filed against patients in 2024 in one U.S. state, physician practices and other non-hospital healthcare entities accounted for 80% of cases. That’s a complete inversion from just six years prior.
Altogether, members of the specialty collected nearly 5,800 of these payments in 2024, from sources such as pharmaceutical companies and imaging device manufacturers.
